Atherothrombosis: The role of tissue factor

Juan Viles Gonzalez, Juan J. Badimon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Atherothrombosis, defined as atherosclerotic lesion disruption with superimposed thrombus formation, is the major cause of acute coronary syndromes and cardiovascular deaths. It is the leading cause of morbidity and mortality in the industrialized world. Plaque composition, rather than luminal stenosis, is recognized as the major determinant of this disease. Since tissue factor is found within atheroma and also in the bloodstream of atherosclerotic patients, it likely plays a key role in determining both plaque and blood thrombogenicity. Ongoing clinical and preclinical studies are evaluating the therapeutic possibilities of specific inhibition of the tissue factor pathway. Here, we will review the role of tissue factor in atherothrombosis.

Original languageEnglish
Pages (from-to)25-30
Number of pages6
JournalInternational Journal of Biochemistry and Cell Biology
Volume36
Issue number1
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Thromboplastin
Atherosclerotic Plaques
Acute Coronary Syndrome
Pathologic Constriction
Thrombosis
Blood
Morbidity
Mortality
Chemical analysis
Therapeutics

Keywords

  • Antithrombotic therapy
  • Atherosclerosis
  • Atherothrombosis
  • Tissue factor
  • Tissue factor pathway inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Atherothrombosis : The role of tissue factor. / Viles Gonzalez, Juan; Badimon, Juan J.

In: International Journal of Biochemistry and Cell Biology, Vol. 36, No. 1, 01.01.2004, p. 25-30.

Research output: Contribution to journalArticle

Viles Gonzalez, Juan ; Badimon, Juan J. / Atherothrombosis : The role of tissue factor. In: International Journal of Biochemistry and Cell Biology. 2004 ; Vol. 36, No. 1. pp. 25-30.
@article{5123abfc568148d8ad91ca50c4acaad4,
title = "Atherothrombosis: The role of tissue factor",
abstract = "Atherothrombosis, defined as atherosclerotic lesion disruption with superimposed thrombus formation, is the major cause of acute coronary syndromes and cardiovascular deaths. It is the leading cause of morbidity and mortality in the industrialized world. Plaque composition, rather than luminal stenosis, is recognized as the major determinant of this disease. Since tissue factor is found within atheroma and also in the bloodstream of atherosclerotic patients, it likely plays a key role in determining both plaque and blood thrombogenicity. Ongoing clinical and preclinical studies are evaluating the therapeutic possibilities of specific inhibition of the tissue factor pathway. Here, we will review the role of tissue factor in atherothrombosis.",
keywords = "Antithrombotic therapy, Atherosclerosis, Atherothrombosis, Tissue factor, Tissue factor pathway inhibitor",
author = "{Viles Gonzalez}, Juan and Badimon, {Juan J.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S1357-2725(03)00240-1",
language = "English",
volume = "36",
pages = "25--30",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Atherothrombosis

T2 - The role of tissue factor

AU - Viles Gonzalez, Juan

AU - Badimon, Juan J.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Atherothrombosis, defined as atherosclerotic lesion disruption with superimposed thrombus formation, is the major cause of acute coronary syndromes and cardiovascular deaths. It is the leading cause of morbidity and mortality in the industrialized world. Plaque composition, rather than luminal stenosis, is recognized as the major determinant of this disease. Since tissue factor is found within atheroma and also in the bloodstream of atherosclerotic patients, it likely plays a key role in determining both plaque and blood thrombogenicity. Ongoing clinical and preclinical studies are evaluating the therapeutic possibilities of specific inhibition of the tissue factor pathway. Here, we will review the role of tissue factor in atherothrombosis.

AB - Atherothrombosis, defined as atherosclerotic lesion disruption with superimposed thrombus formation, is the major cause of acute coronary syndromes and cardiovascular deaths. It is the leading cause of morbidity and mortality in the industrialized world. Plaque composition, rather than luminal stenosis, is recognized as the major determinant of this disease. Since tissue factor is found within atheroma and also in the bloodstream of atherosclerotic patients, it likely plays a key role in determining both plaque and blood thrombogenicity. Ongoing clinical and preclinical studies are evaluating the therapeutic possibilities of specific inhibition of the tissue factor pathway. Here, we will review the role of tissue factor in atherothrombosis.

KW - Antithrombotic therapy

KW - Atherosclerosis

KW - Atherothrombosis

KW - Tissue factor

KW - Tissue factor pathway inhibitor

UR - http://www.scopus.com/inward/record.url?scp=0242380207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242380207&partnerID=8YFLogxK

U2 - 10.1016/S1357-2725(03)00240-1

DO - 10.1016/S1357-2725(03)00240-1

M3 - Article

C2 - 14592530

AN - SCOPUS:0242380207

VL - 36

SP - 25

EP - 30

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

IS - 1

ER -